{"log_id": 5151272409593827562, "direction": 0, "words_result_num": 46, "words_result": [{"probability": {"variance": 7.4e-05, "average": 0.992202, "min": 0.978046}, "location": {"width": 80, "top": 148, "height": 23, "left": 171}, "words": "核准日期:"}, {"probability": {"variance": 0.001827, "average": 0.973629, "min": 0.868148}, "location": {"width": 439, "top": 185, "height": 32, "left": 419}, "words": "注射用重组人白细胞介素-11(rhIL-11)使用说明书"}, {"probability": {"variance": 4e-06, "average": 0.998418, "min": 0.99342}, "location": {"width": 322, "top": 212, "height": 29, "left": 475}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 1e-06, "average": 0.999453, "min": 0.997994}, "location": {"width": 79, "top": 289, "height": 24, "left": 180}, "words": "药品名称"}, {"probability": {"variance": 0.00675, "average": 0.971782, "min": 0.635035}, "location": {"width": 328, "top": 319, "height": 30, "left": 171}, "words": "通用名称:注射用重组人白细胞介素-11"}, {"probability": {"variance": 3e-06, "average": 0.998788, "min": 0.994495}, "location": {"width": 154, "top": 357, "height": 24, "left": 171}, "words": "商品名称:特尔康"}, {"probability": {"variance": 0.000174, "average": 0.993449, "min": 0.96132}, "location": {"width": 113, "top": 391, "height": 22, "left": 171}, "words": "英文名称:Re"}, {"probability": {"variance": 2e-06, "average": 0.996418, "min": 0.994895}, "location": {"width": 73, "top": 390, "height": 18, "left": 378}, "words": " Human In"}, {"probability": {"variance": 0, "average": 1, "min": 1}, "location": {"width": 53, "top": 388, "height": 19, "left": 511}, "words": " kin-1i"}, {"probability": {"variance": 1.6e-05, "average": 0.99727, "min": 0.987533}, "location": {"width": 115, "top": 423, "height": 23, "left": 170}, "words": "汉语拼音:Zh"}, {"probability": {"variance": 1e-06, "average": 0.998719, "min": 0.997971}, "location": {"width": 56, "top": 422, "height": 18, "left": 443}, "words": " Ren Ba"}, {"probability": {"variance": 9.1e-05, "average": 0.980031, "min": 0.9705}, "location": {"width": 103, "top": 420, "height": 20, "left": 565}, "words": " Jiesu Shiyi"}, {"probability": {"variance": 0.000888, "average": 0.976714, "min": 0.934578}, "location": {"width": 49, "top": 458, "height": 22, "left": 187}, "words": "成份]"}, {"probability": {"variance": 0.004393, "average": 0.977412, "min": 0.606906}, "location": {"width": 738, "top": 479, "height": 36, "left": 170}, "words": "活性成份:重组人白细胞介素-11,来源于含有高效表达人白细胞介素-11基因的大肠杆菌"}, {"probability": {"variance": 7.1e-05, "average": 0.997092, "min": 0.959583}, "location": {"width": 396, "top": 519, "height": 30, "left": 171}, "words": "非活性成份:甘氨酸、磷酸二氢钠、磷酸氢二钠"}, {"probability": {"variance": 1.7e-05, "average": 0.994331, "min": 0.989043}, "location": {"width": 44, "top": 558, "height": 21, "left": 187}, "words": "[性状"}, {"probability": {"variance": 3e-06, "average": 0.998935, "min": 0.992406}, "location": {"width": 380, "top": 576, "height": 31, "left": 172}, "words": "应为类白色疏松体,加注射用水后能迅速溶解"}, {"probability": {"variance": 0, "average": 0.999727, "min": 0.999325}, "location": {"width": 61, "top": 616, "height": 20, "left": 191}, "words": "适应症"}, {"probability": {"variance": 1e-05, "average": 0.998072, "min": 0.985609}, "location": {"width": 940, "top": 636, "height": 38, "left": 171}, "words": "用于实体瘤、非性白血病化疗后Ⅲ、Ⅳ度血小板减少症的治疗:实体瘤及非髓性白血病患者,前一疗程化疗后发"}, {"probability": {"variance": 0.00511, "average": 0.97478, "min": 0.605832}, "location": {"width": 937, "top": 669, "height": 37, "left": 174}, "words": "生Ⅲ/Ⅳ度血小板减少症(即血小板数≤50810°)者,下一疗程化疗前使用本品,以减少病人因血小板减少引起的"}, {"probability": {"variance": 0.005005, "average": 0.98072, "min": 0.549797}, "location": {"width": 852, "top": 705, "height": 32, "left": 173}, "words": "出血和对血小板输注的依赖性、同时有白细胞减少症的病人必要时可合并使用重组人粒细胞刺激因子(x"}, {"probability": {"variance": 0.000306, "average": 0.984957, "min": 0.954686}, "location": {"width": 59, "top": 748, "height": 23, "left": 182}, "words": "[规格]"}, {"probability": {"variance": 0.00757, "average": 0.959724, "min": 0.660825}, "location": {"width": 489, "top": 777, "height": 29, "left": 180}, "words": "mg(800万单位)/支海支用0.ml的灭菌注射用水复溶"}, {"probability": {"variance": 3.6e-05, "average": 0.98775, "min": 0.978835}, "location": {"width": 98, "top": 815, "height": 22, "left": 172}, "words": "[用法用量]"}, {"probability": {"variance": 0.007933, "average": 0.970766, "min": 0.561997}, "location": {"width": 904, "top": 837, "height": 38, "left": 209}, "words": "根椐本品临床研究结果,推荐品应用剂量为25-50g/kg体重,于化疗结束后24-48小时开始或发生血小板"}, {"probability": {"variance": 0.018531, "average": 0.95779, "min": 0.357357}, "location": {"width": 668, "top": 872, "height": 32, "left": 171}, "words": "减少症后皮下注射,每日一次一身程子般14天。血小板计数恢复后应及时停药"}, {"probability": {"variance": 1e-06, "average": 0.99887, "min": 0.996588}, "location": {"width": 285, "top": 913, "height": 25, "left": 208}, "words": "用规定体积的注射用水溶解后使用"}, {"probability": {"variance": 1e-06, "average": 0.999288, "min": 0.997327}, "location": {"width": 90, "top": 949, "height": 23, "left": 190}, "words": "不良反应]"}, {"probability": {"variance": 0.001025, "average": 0.992938, "min": 0.775315}, "location": {"width": 895, "top": 973, "height": 35, "left": 215}, "words": "国外临床研究报道:除了化疗本身的不良反应外,重组人白细胞介素-11的大部分不良反应均为轻至中度,且"}, {"probability": {"variance": 4e-06, "average": 0.99875, "min": 0.991312}, "location": {"width": 922, "top": 1008, "height": 32, "left": 171}, "words": "停药后均能迅速消退。约有10%的临床病人在观察期间有下列一些不良事件出现,包括乏力、疼痛、寒颤、腹痛"}, {"probability": {"variance": 2e-05, "average": 0.998558, "min": 0.968679}, "location": {"width": 940, "top": 1040, "height": 35, "left": 171}, "words": "感染、恶心、便秘、消化不良、淤斑、肌痛、骨痛、神经紧张及脱发等。其中大部分事件的发生率与安慰剂对照组"}, {"probability": {"variance": 2.4e-05, "average": 0.997833, "min": 0.975754}, "location": {"width": 436, "top": 1078, "height": 29, "left": 171}, "words": "相似,发生率高于安慰剂对照组的临床不良反应包括"}, {"probability": {"variance": 1e-06, "average": 0.999343, "min": 0.996535}, "location": {"width": 435, "top": 1111, "height": 29, "left": 215}, "words": "全身性:水肿、头痛、发热及中性粒细胞减少性发热"}, {"probability": {"variance": 3.8e-05, "average": 0.996444, "min": 0.975897}, "location": {"width": 509, "top": 1143, "height": 30, "left": 215}, "words": "心血管系统:心动过速、血管扩张、心悸、晕厥、房颤及房扑"}, {"probability": {"variance": 0.000234, "average": 0.99515, "min": 0.922917}, "location": {"width": 471, "top": 1178, "height": 28, "left": 214}, "words": "消化系统:恶心、呕吐、粘膜炎、腹泻、口腔念珠菌感染"}, {"probability": {"variance": 0.009943, "average": 0.965688, "min": 0.66656}, "location": {"width": 193, "top": 1214, "height": 24, "left": 214}, "words": "神经系统:眩晕、失眠"}, {"probability": {"variance": 0.002794, "average": 0.985105, "min": 0.715864}, "location": {"width": 520, "top": 1244, "height": 27, "left": 213}, "words": "呼吸系统:呼吸困难、鼻炎、咳嗽次数增加,咽炎、胸膜液渗出"}, {"probability": {"variance": 0.000469, "average": 0.99077, "min": 0.900844}, "location": {"width": 436, "top": 1279, "height": 25, "left": 213}, "words": "其他:皮疹、结膜充血、偶见用药后一过性视力模糊"}, {"probability": {"variance": 0.000433, "average": 0.995263, "min": 0.855184}, "location": {"width": 903, "top": 1310, "height": 28, "left": 207}, "words": "此外,弱视、感觉异常、脱水、皮肤褪色、表皮剥脱性皮炎及眼出血等不良反应,治疗组病人中的发生率也高"}, {"probability": {"variance": 0.004357, "average": 0.981661, "min": 0.57962}, "location": {"width": 939, "top": 1344, "height": 29, "left": 171}, "words": "于安慰剂对照组,但统计处理不能确定这些不良反应事件的发生与重组人白细胞介素-11的使用有关联性。除了弱"}, {"probability": {"variance": 0.000375, "average": 0.994144, "min": 0.86022}, "location": {"width": 938, "top": 1379, "height": 25, "left": 172}, "words": "视的发生治疗组(10例[14%])显著高于对照组(2例[3%])外,两组间其它一些严重的或危及生命的不良反应事"}, {"probability": {"variance": 0.000125, "average": 0.994411, "min": 0.963299}, "location": {"width": 169, "top": 1415, "height": 23, "left": 172}, "words": "件的发生率大致相当"}, {"probability": {"variance": 0.000819, "average": 0.99251, "min": 0.801434}, "location": {"width": 896, "top": 1446, "height": 26, "left": 214}, "words": "两例病人在观察期间发生猝死,研究人员认为病人死亡的原因可能部分与用药有关。这两例病人均使用了大剂"}, {"probability": {"variance": 0.007228, "average": 0.964127, "min": 0.518236}, "location": {"width": 938, "top": 1480, "height": 24, "left": 171}, "words": "量环磷酰胺进行化疗,当时仍每日使用利尿剂,且均伴有严重的低钾血症(<3.0nEq/L)。因此,猝死的发生与熏组"}, {"probability": {"variance": 0.011854, "average": 0.97076, "min": 0.485369}, "location": {"width": 390, "top": 1515, "height": 23, "left": 170}, "words": "人白细胞介-11的使用之间的关系仍无法确定"}, {"probability": {"variance": 0.009088, "average": 0.965576, "min": 0.431805}, "location": {"width": 890, "top": 1545, "height": 27, "left": 213}, "words": "实验室检查中用药病人最常见的化验指标异常为因血浆容量的扩张引起的血红蛋白浓度降低,血浆容量的扩"}], "language": 3}